Repligen Corp. (RGEN)
119.99
-5.04
(-4.03%)
USD |
NASDAQ |
Mar 06, 16:00
120.02
+0.03
(+0.03%)
After-Hours: 20:00
Repligen SG&A Expense (TTM) : 290.51M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Masimo Corp. | 374.70M |
| Orthofix Medical, Inc. | 554.33M |
| InfuSystem Holdings, Inc. | 67.46M |
| Tandem Diabetes Care, Inc. | 444.99M |
| Plus Therapeutics, Inc. | 11.09M |